Novus Therapeutics, Inc (NVUS) PT Lowered to $3.25 at Ascendiant Capital
Tweet
Share
E-mailGet Alerts NVUS Hot Sheet
Price: $14.60 --0%
Rating Summary:
3 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Rating Summary:
3 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Join SI Premium – FREE
Ascendiant Capital analyst Edward Woo lowered the price target on Novus Therapeutics, Inc (NASDAQ: NVUS) to $3.25 (from $3.50) while maintaining a Buy rating.
You May Also Be Interested In
- Citi Downgrades ICICI Prudential Life Insurance Co Ltd. (IPRU:IN) to Neutral
- UBS Upgrades Swiss Prime Site AG (SPSN:SW) (SWPRF) to Buy
- Novartis (NOVN:SW) (NVS) PT Raised to CHF95 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
